Skip to content Skip to footer
VIEWPOINTS_Laura Niklason_2023

Laura Niklason, Founder, President, and CEO of Humacyte Shares her Views from the HAV™ Coronary Artery Bypass Graft Data Presented at the AHA Scientific Sessions 2022

Shots: Laura gave an overview of Human acellular vessels (HAV). She talked about the six-month results of the HAV in a non-human primate model of CABG presented at the annual American Heart Association (AHA) Scientific Sessions 2022 She also elaborated on the construction and development of the CABG model and how it treats blocked arteries…

Read more

Sign Up to Our Newsletter

Be the first to know the latest updates

[mc4wp_form id="13387" element_id="style-1"]